Alethea Capital Management’s Johnson & Johnson JNJ Stock Holding History

Alethea Capital Management’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-3,323	Closed	-$616K	–	22
2025 Q3	$616K	Buy	+3,323	New	+$569K	0.4%	6
2021 Q3	–	Sell	-4,062	Closed	-$669K	–	99
2021 Q2	$669K	Buy	+4,062	New	+$672K	0.42%	32
2020 Q4	–	Sell	-4,419	Closed	-$658K	–	85
2020 Q3	$658K	Buy	4,419 +1,045	+31%	+$155K	0.45%	28
2020 Q2	$474K	Buy	+3,374	New	+$492K	0.28%	45
2020 Q1	–	Sell	-2,759	Closed	-$402K	–	95
2019 Q4	$402K	Hold	2,759	–	–	0.17%	54
2019 Q3	$357K	Hold	2,759	–	–	0.23%	60
2019 Q2	$384K	Sell	2,759 -12,240	-82%	-$1.69M	0.25%	61
2019 Q1	$2.1M	Buy	+14,999	New	+$2.01M	1.49%	8
2018 Q2	–	Sell	-7,098	Closed	-$910K	–	87
2018 Q1	$910K	Buy	+7,098	New	+$959K	1.23%	18
2017 Q1	–	Sell	-17,256	Closed	-$1.99M	–	90
2016 Q4	$1.99M	Buy	+17,256	New	+$1.99M	2.51%	13
2015 Q2	–	Sell	-5,105	Closed	-$514K	–	84
2015 Q1	$514K	Sell	5,105 -2,000	-28%	-$203K	0.57%	33
2014 Q4	$743K	Buy	+7,105	New	+$749K	0.76%	41

Other funds holding JNJ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Alethea Capital Management's JNJ Position: Q4 2025 in Review

Alethea Capital Management sold out of Johnson & Johnson (JNJ) in Q4 2025, closing a stake of 3,323 shares — an estimated $616K sold.

Alethea Capital Management first reported a position in JNJ in Q4 2014 and held it in 12 quarters. The position peaked at $2.1M in Q1 2019. 4,520 funds tracked by Wall St. Rank hold JNJ as of Q4 2025.

Alethea Capital Management reported no remaining Johnson & Johnson position as of Q4 2025 after selling out during the quarter.
Alethea Capital Management sold 3,323 Johnson & Johnson shares in Q4 2025, an estimated $616K.
Alethea Capital Management first reported a position in Johnson & Johnson in Q4 2014 and held it in 12 quarters.
Alethea Capital Management's Johnson & Johnson position peaked at $2.1M in Q1 2019.
4,520 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2025.

Based on Alethea Capital Management's 13F filing for Q4 2025, filed 11 Feb 2026.